Cellectis
Cellectis is a Paris-based biotechnology company founded in 1999 by André Choulika and David Sourdive. It develops in vivo gene-editing medicines for chronic diseases using a programmable genome-engineering platform, alongside partnered cell-therapy programs.
Key facts
| Legal Name | Cellectis S.A. |
|---|---|
| Company Operating Status | Active |
| Full Address | 8 RUE DE LA CROIX JARRY 75013, PARIS, ILE-DE-FRANCEFrance |
| Stock Symbol | CLLS |
| Ticker Symbol | CLLS |
| Wikidata ID | Q2943995 |
Contact details
Email and phone for Cellectis are available to signed-in members of CliffBio.
Sign in to view